Explore the vast range of titles available.

Dynamic change of mitochondrial morphology and distribution along neuronal branches are essential for neural circuitry formation and synaptic efficacy. However, the underlying mechanism remains elusive. We show here that Pink1 knockout (KO) mice display defective dendritic spine maturation, reduced axonal synaptic vesicles, abnormal synaptic connection, and attenuated long-term synaptic potentiation (LTP). Drp1 activation via S616 phosphorylation rescues deficits of spine maturation in Pink1 KO neurons. Notably, mice harboring a knockin (KI) phosphor-null Drp1 S616A recapitulate spine immaturity and synaptic abnormality identified in Pink1 KO mice. Chemical LTP (cLTP) induces Drp1 S616 phosphorylation in a PINK1-dependent manner. Moreover, phosphor-mimetic Drp1 S616D restores reduced dendritic spine localization of mitochondria in Pink1 KO neurons. Together, this study provides the first in vivo evidence of functional regulation of Drp1 by phosphorylation and suggests that PINK1-Drp1 S616 phosphorylation coupling is essential for convergence between mitochondrial dynamics and neural circuitry formation and refinement.

A novel hexapeptide LVVLGH (LH-6) from the thick-shelled mussel (Mytilus coruscus) demonstrated potent immune-enhancing effects in RAW264.7 cells in vitro, but its immunological activity in vivo is unclear. As a result, the present study was designed to investigate the in vivo effects of LH-6 on cyclophosphamide-induced immunodeficient mice. The results demonstrate that LH-6 promoted the growth and development of immunodeficient mice in a concentration-dependent manner, remarkably elevated the immune organ index, and relieved the pathological characteristics of the spleen and thymus. Additional experiments also revealed that LH-6 effectively promoted the multiplication of splenic lymphocytes and natural killer activity, enhanced the function of abdominal macrophages, and apparently recovered delayed-type hypersensitivity in immunodeficient mice. The secretion of IgA, IgG, IgM, TNF-α, IL-1β, IL-6, and serum hemolysin were remarkably improved by LH-6, suggesting that LH-6 can synergistically strengthen cellular and humoral immunity. In addition, LH-6 promoted the phosphorylation of IκBα and nuclear translocation of p65, which correspondingly increased the phosphorylation levels of p38, JNK, and ERK; activated the NF-κB and MAPK pathways; and exerted in vivo immunomodulatory activities. Docking results show that LH-6 has favorable binding energies to candidate proteins in the NF-κB and MAPK pathways. To summarize, this research further demonstrated that LH-6 possesses in vivo immunomodulatory activity, which provides a possibility for the subsequent development of immune-enhancing functional foods.

A novel hexapeptide LVVLGH (LH-6) from the thick-shelled mussel (Mytilus coruscus) demonstrated potent immune-enhancing effects in RAW264.7 cells in vitro, but its immunological activity in vivo is unclear. As a result, the present study was designed to investigate the in vivo effects of LH-6 on cyclophosphamide-induced immunodeficient mice. The results demonstrate that LH-6 promoted the growth and development of immunodeficient mice in a concentration-dependent manner, remarkably elevated the immune organ index, and relieved the pathological characteristics of the spleen and thymus. Additional experiments also revealed that LH-6 effectively promoted the multiplication of splenic lymphocytes and natural killer activity, enhanced the function of abdominal macrophages, and apparently recovered delayed-type hypersensitivity in immunodeficient mice. The secretion of IgA, IgG, IgM, TNF-α, IL-1β, IL-6, and serum hemolysin were remarkably improved by LH-6, suggesting that LH-6 can synergistically strengthen cellular and humoral immunity. In addition, LH-6 promoted the phosphorylation of IκBα and nuclear translocation of p65, which correspondingly increased the phosphorylation levels of p38, JNK, and ERK; activated the NF-κB and MAPK pathways; and exerted in vivo immunomodulatory activities. Docking results show that LH-6 has favorable binding energies to candidate proteins in the NF-κB and MAPK pathways. To summarize, this research further demonstrated that LH-6 possesses in vivo immunomodulatory activity, which provides a possibility for the subsequent development of immune-enhancing functional foods.

Dynamic change of mitochondrial morphology and distribution along neuronal branches are essential for neural circuitry formation and synaptic efficacy. However, the underlying mechanism remains elusive. We show here that Pink1 knockout (KO) mice display defective dendritic spine maturation, reduced axonal synaptic vesicles, abnormal synaptic connection, and attenuated long-term synaptic potentiation (LTP). Drp1 activation via S616 phosphorylation rescues deficits of spine maturation in Pink1 KO neurons. Notably, mice harboring a knockin (KI) phosphor-null Drp1 recapitulate spine immaturity and synaptic abnormality identified in Pink1 KO mice. Chemical LTP (cLTP) induces Drp1 phosphorylation in a PINK1-dependent manner. Moreover, phosphor-mimetic Drp1 restores reduced dendritic spine localization of mitochondria in Pink1 KO neurons. Together, this study provides the first in vivo evidence of functional regulation of Drp1 by phosphorylation and suggests that PINK1-Drp1 phosphorylation coupling is essential for convergence between mitochondrial dynamics and neural circuitry formation and refinement.

Addressing burdens of electronic waste (E-waste) leachate while achieving sustainable and selective recovery of noble metals, such as gold, is highly demanded due to its limited supply and escalating prices. Here we demonstrate an environmentally-benign and practical approach for gold recovery from E-waste leachate using alginate-derived pyrocarbon sorbent. The sorbent demonstrates potent gold recovery performance compared to most previously reported advanced sorbents, showcasing high recovery capacity of 2829.7 mg g −1 , high efficiency (>99.5%), remarkable selectivity ( K d  ~ 3.1 × 10 8 mL g −1 ), and robust anti-interference capabilities within environmentally relevant contexts. The aromatic structures of pyrocarbon serve as crucial electrons sources, enabling a hydroxylation process that simultaneously generates electrons and phenolic hydroxyls for the reduction of gold ions. Our investigations further uncover a “stepwise” nucleation mechanism, in which gold ions are reduced as intermediate gold-chlorine clusters, facilitating rapid reduction process by lowering energy barriers from 1.08 to −21.84 eV. Technoeconomic analysis demonstrates its economic viability with an input-output ratio as high as 1370%. Our protocol obviates the necessity for organic reagents whilst obtaining 23.96 karats gold product from real-world central processing units (CPUs) leachates. This work introduces a green sorption technique for gold recovery, emphasizing its role in promoting a circular economy and environmental sustainability. The demand for gold recovery from E-Waste is significant due to its high value. Here, authors present a practical method for extracting gold from an actual E-waste leachate using alginate-derived pyrocarbon. This approach yields a 23.96 karat gold product and demonstrates strong economic viability.

Effective treatment of per- and polyfluoroalkyl substances (PFAS) in an affordable manner is highly demanded to meet stringent water protection standards. Herein, we introduce a fluoroamine dual-site hydrogel (QFgel) designed to structurally match amphipathic PFAS molecules, facilitating selective interactions for the effective PFAS removal from water. Specifically, the synergistic effects of quaternized and fluorinated functional groups in QFgel can promote electrostatic-fluorophilic dual-site interactions with both the perfluoroalkyl and anionic headgroups at the ends of PFAS. As a result, these dual-site interactions achieve high selectivity (sorption coefficients ranging from 1.75 to 4.0) and ultrahigh sorption capacity (up to 2,835 mg g -1 ), resulting in over 95.6% removal of 17 PFAS types at environmentally relevant concentrations in real water matrices. Notably, pilot-scale applications with a kilogram-scale QFgel-adsorber effectively treats up to 12,400 and 9,215 bed volumes of PFAS-contaminated drinking water (i.e., tap water) before the breakthrough point of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) ([PFAS] 0  = ~ 0.35 µg L -1 , 2 m 3 per day). After 46 days of continuous operation, the adsorber is regenerated using a saline-methanol mixed eluent, achieving 96.5% desorption and up to 1,633-fold PFAS enrichment, while reducing eluent use by 70% compared to commercial sorbents. This work advances PFAS remediation by offering a scalable, cost-effective solution, and contributes to sustainable water resource protection. PFAS poses significant threats to human health and aquatic ecosystems. Here, a fluoroamine-functionalized QFgel is proposed and exhibits high selectivity and removal efficiency for 17 PFAS in water at environmentally relevant concentrations.

Enhanced electromechanical response can commonly be found during the crossover from normal to relaxor ferroelectric state, making relaxors to be potential candidates for actuators. In this work, (Pb 0.917 La 0.083 )(Zr 0.65 Ti 0.35 ) 0.97925 O 3 ceramic was taken as a case study, which shows a critical nonergodic state with both double-like P-E loop and irreversible relaxor-normal ferroelectric phase after poling at room temperature. The low-hysteresis linear-like S-P 2 loop, in-situ synchrotron X-ray diffraction and transmission electron microscope results suggest that the nonpolar relaxor state acts as a bridge during polarization reorientation process, accompanying which lattice strain contributes to 61.8% of the total strain. In other words, the transformation from normal ferroelectric to nonergodic relaxor state could be triggered by electric field through polarization contraction, which could change to be spontaneously with slightly increasing temperature in the nonergodic relaxor zone. Therefore, pseudo-ergodicity in nonergodic relaxors (i.e. reversible nonergodic-normal ferroelectric phase transition) driven by periodic electric field should be the main mechanism for obtaining large electrostrain close to the nonergodic-ergodic relaxor boundary. This work provides new insights into polarization reorientation process in relaxor ferroelectrics, especially phase instability in nonergodic relaxor zone approaching to freezing temperature. High-performance relaxor ferroelectrics have been widely used in industry. Here the authors show that the enhanced electromechanical response is related to the pseudo ergodicity of nonergodic relaxor ferroelectrics under periodic electric field.

Parkinson’s disease is a progressive neurodegenerative disorder resulting from the degeneration of pigmented dopaminergic neurons in the substantia nigra pars compacta. It induces a series of functional modifications in the circuitry of the basal ganglia nuclei and leads to severe motor disturbances. The amino acid glutamate, as an excitatory neurotransmitter, plays a key role in the disruption of normal basal ganglia function regulated through the interaction with its receptor proteins. It has been proven that glutamate receptors participate in the modulation of neuronal excitability, transmitter release, and long-term synaptic plasticity, in addition to being related to the altered neurotransmission in Parkinson’s disease. Therefore, they are considered new targets for improving the therapeutic strategies used to treat Parkinson’s disease. In this review, we discuss the biological characteristics of these receptors and demonstrate the receptor-mediated neuroprotection in Parkinson’s disease. Pharmacological manipulation of these receptors during anti-Parkinsonian processes in both experimental studies and clinical trials are also summarized.

In this multicenter, single-arm phase 2 trial (ChiCTR1900024428), patients with locally advanced gastric/gastroesophageal junction cancers receive one cycle of sintilimab (anti-PD1) and chemotherapy (S-1 and nab-paclitaxel), followed by 5 weeks of concurrent chemoradiotherapy and sintilimab, and another cycle of sintilimab and chemotherapy thereafter. Surgery is preferably scheduled within one to three weeks, and three cycles of adjuvant sintilimab and chemotherapy are administrated. The primary endpoint is the pathological complete response. Our results meet the pre-specified primary endpoint. Thirteen of 34 (38.2%) enrolled patients achieve pathological complete response (95% CI: 22.2-56.4). The secondary objectives include disease-free survival (DFS), major pathological response, R0 resection rate, overall survival (OS), event-free survival (EFS), and safety profile. The median DFS and EFS were 17.0 (95%CI: 11.1-20.9) and 21.1 (95%CI: 14.7-26.1) months, respectively, while the median OS was not reached, and the 1-year OS rate was 92.6% (95%CI: 50.1-99.5%). Seventeen patients (50.0%) have grade ≥3 adverse events during preoperative therapy. In prespecified exploratory biomarker analysis, CD3 + T cells, CD56 + NK cells, and the M1/M1 + M2-like macrophage infiltration at baseline are associated with pathological complete response. Here, we show the promising efficacy and manageable safety profile of sintilimab in combination with concurrent chemoradiotherapy for the perioperative treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma. Neoadjuvant chemotherapy followed by gastrectomy is considered standard of care for locally advanced gastric and gastroesophageal junction (G/GEJ) cancers. Here the authors report the results of a phase 2 trial of neoadjuvant sintilimab (anti-PD1) plus chemoradiotherapy in patients with locally advanced G/GEJ tumors.

Microbially mediated biological nitrogen fixation is pivotal to sustainable agricultural development. However, optimizing nitrogenase activity in native biological nitrogen-fixing bacteria has been hindered by the complexities of genetic manipulation. Heterologous expression has served as a foundational strategy for engineering next-generation nitrogen-fixing microbial agents. In this study, genomic analysis of Paenibacillus polymyxa CR1 revealed an 11 kb nitrogen-fixing (nif) gene cluster. The nif cluster was first synthesized and then assembled using ExoCET technology and finally integrated into the genome of Bacillus subtilis 168 via double-exchange recombination. RT-PCR confirmed the transcription of the nif cluster; however, no nitrogenase activity was detected in the acetylene reduction assay. A promoter replacement strategy (replacing the native promoter with Pveg) enabled B. subtilis to produce active nitrogenase. However, stronger promoters—namely, P43 and Ptp2—did not further enhance nitrogenase activity. This demonstrates that promoter selection requires balancing transcriptional strength with systemic compatibility, particularly for metalloenzymes demanding precise cofactor assembly. This is the first report describing the heterologous expression of the nif gene cluster in B. subtilis, establishing a foundation for engineering high-efficiency nitrogen-fixing biofertilizers.